Alessandro Bonardi Selected Research

Alessandro Bonardi Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 02/2018
5	Glaucoma 01/2022 - 10/2019
3	Neuralgia (Stump Neuralgia) 10/2023 - 01/2021
2	Neoplasm Metastasis (Metastasis) 10/2023 - 02/2018
2	Chagas Disease (American Trypanosomiasis) 12/2022 - 04/2019
1	Type 2 Diabetes Mellitus (MODY) 04/2024
1	Diabetes Mellitus 04/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2024
1	Amyloid Plaque 03/2024
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Tuberculosis (Tuberculoses) 02/2024
1	Hypoxia (Hypoxemia) 10/2023
1	Pain (Aches) 10/2022
1	Arthritis (Polyarthritis) 10/2022
1	Epilepsy (Aura) 01/2022
1	Altitude Sickness (Mountain Sickness) 01/2022
1	Edema (Dropsy) 01/2022
1	Colitis 01/2021
1	Visceral Pain 01/2021
1	Breast Neoplasms (Breast Cancer) 03/2020
1	Ocular Hypertension (Glaucoma, Suspect) 10/2019
1	Kidney Neoplasms (Kidney Cancer) 05/2019
1	Leishmaniasis 04/2019
1	Colonic Neoplasms (Colon Cancer) 02/2018

Drug/Important Bio-Agent (IBA)

20	Protein Isoforms (Isoforms)IBA 03/2024 - 02/2018
19	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2024 - 02/2018
7	SulfonamidesIBA 10/2023 - 12/2019
5	BenzenesulfonamidesIBA 04/2024 - 05/2018
3	EnzymesIBA 04/2024 - 11/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 01/2023
3	SLC-0111IBA 10/2023 - 12/2022
3	Carbonic Anhydrase InhibitorsIBA 01/2023 - 04/2019
2	LigandsIBA 04/2024 - 03/2024
2	coumarinIBA 01/2024 - 03/2020
2	CoumarinsIBA 11/2020 - 02/2018
1	Carbonic Anhydrase IIIBA 04/2024
1	GlucosidasesIBA 04/2024
1	Organophosphonates (Phosphonates)IBA 03/2024
1	Methazolamide FDA LinkGeneric 03/2024
1	Monoamine Oxidase (MAO)IBA 03/2024
1	Peptides (Polypeptides)IBA 03/2024
1	Cholinergic Agents (Cholinergics)IBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024
1	Amyloid (Amyloid Fibrils)IBA 03/2024
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2024
1	Isoniazid (Ftivazide)FDA LinkGeneric 02/2024
1	Propidium (Propidium Iodide)IBA 12/2023
1	Cytotoxins (Cytolysins)IBA 12/2023
1	Organoselenium CompoundsIBA 12/2023
1	FITC-annexin A5IBA 12/2023
1	SeleniumIBA 12/2023
1	IsoenzymesIBA 10/2023
1	Biotin (Vitamin H)FDA Link 10/2023
1	cathepsin SIBA 10/2023
1	compound 30IBA 06/2023
1	ZincIBA 06/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	benzothiazoleIBA 12/2022
1	Antiprotozoal AgentsIBA 12/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2022
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 10/2022
1	pyrazoleIBA 01/2022
1	KetonesIBA 01/2022
1	Sulfanilamide FDA Link 01/2022
1	piperineIBA 12/2021
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2021
1	Sulfonic AcidsIBA 01/2021
1	Carbonic Anhydrase IVIBA 01/2021
1	FuraginIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	pyrimidineIBA 03/2020
1	Fluorouracil (Carac)FDA LinkGeneric 03/2020
1	Carbonic Anhydrase IXIBA 03/2020
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2020
1	isoquinolineIBA 10/2019
1	AmidesIBA 10/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2019
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 10/2019
1	ProstaglandinsIBA 10/2019
1	benzamideIBA 10/2019
1	rho-Associated KinasesIBA 10/2019
1	Muscarinic AgonistsIBA 10/2019
1	K-115IBA 10/2019
1	DiamideIBA 05/2019
1	SaltsIBA 04/2019
1	SteroidsIBA 12/2018

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2018